ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,652,958 | -24.6% | 247,598 | 0.0% | 2.45% | -10.6% |
| Q2 2023 | $8,829,345 | +40.4% | 247,598 | 0.0% | 2.74% | +34.0% |
| Q1 2023 | $6,288,989 | +62520.6% | 247,598 | 0.0% | 2.05% | -30.0% |
| Q4 2022 | $10,043 | -99.9% | 247,598 | 0.0% | 2.92% | +21.3% |
| Q3 2022 | $8,183,000 | -81.6% | 247,598 | -80.4% | 2.41% | -78.8% |
| Q2 2022 | $44,395,000 | -23.4% | 1,260,869 | 0.0% | 11.34% | +3.5% |
| Q1 2022 | $57,987,000 | -73.2% | 1,260,869 | -61.3% | 10.96% | -55.5% |
| Q4 2021 | $216,196,000 | +6.2% | 3,260,869 | 0.0% | 24.61% | +37.8% |
| Q3 2021 | $203,576,000 | – | 3,260,869 | – | 17.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |